Recaticimab and Statin
I-24PJ2601
Approved small_molecule active
Quick answer
Recaticimab and Statin for Intracranial Atherosclerosis is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Intracranial Atherosclerosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active